For research use only. Not for therapeutic Use.
NRX-0492（Cat No.:I041287）is an investigational small molecule drug under development for the treatment of neurological disorders, particularly focusing on conditions like depression and schizophrenia. It works by modulating specific brain receptors involved in mood regulation and cognitive function. NRX-0492 has shown potential in preclinical studies for enhancing neurotransmitter activity and improving neural connectivity, which could help address symptoms of mental health disorders. Research is ongoing to evaluate its efficacy, safety, and pharmacokinetics in clinical trials, with the goal of offering a novel, targeted therapeutic approach for patients with challenging psychiatric conditions.
| CAS Number | 2416130-57-7 |
| Synonyms | 3-[4-[1-[[(3S)-1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]pyrrolidin-3-yl]methyl]piperidin-4-yl]anilino]-5-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]pyrazine-2-carboxamide |
| Molecular Formula | C43H51N11O6 |
| Purity | ≥95% |
| IUPAC Name | 3-[4-[1-[[(3S)-1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]pyrrolidin-3-yl]methyl]piperidin-4-yl]anilino]-5-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]pyrazine-2-carboxamide |
| InChI | InChI=1S/C43H51N11O6/c1-49-19-20-53(43(49)60)31-3-2-15-52(25-31)35-22-45-37(38(44)56)39(47-35)46-29-6-4-27(5-7-29)28-13-16-50(17-14-28)23-26-12-18-51(24-26)30-8-9-32-33(21-30)42(59)54(41(32)58)34-10-11-36(55)48-40(34)57/h4-9,21-22,26,28,31,34H,2-3,10-20,23-25H2,1H3,(H2,44,56)(H,46,47)(H,48,55,57)/t26-,31+,34?/m0/s1 |
| InChIKey | WFDYOAWNEOGIPM-NJZOVTIDSA-N |
| SMILES | CN1CCN(C1=O)[C@@H]2CCCN(C2)C3=CN=C(C(=N3)NC4=CC=C(C=C4)C5CCN(CC5)C[C@@H]6CCN(C6)C7=CC8=C(C=C7)C(=O)N(C8=O)C9CCC(=O)NC9=O)C(=O)N |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
